Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Akero Therapeutics, Inc. (AKRO)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | |
|
Returns on Capital |
ROIC (excluding intangibles) | -180.4% | -183.7% | -107.2% | -130.8% | |
ROIC (including intangibles) | -114.9% | -367.4% | -97.3% | -68.0% | -523.3% |
ROE | -35.3% | -59.7% | -31.0% | -35.5% | -18.4% |
ROA | -32.3% | -51.6% | -29.3% | -33.1% | -17.9% |
|
Cash Conversion Cycle |
|